Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence (Q38577921)

4 September 2017

Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence (English)

1 reference

4 September 2017

0 references

Bjorn Jensen

1

1 reference

4 September 2017

Jeffrey Chen

series ordinal

2

1 reference

4 September 2017

Tim Furnish

series ordinal

3

1 reference

4 September 2017

Mark Wallace

series ordinal

4

1 reference

4 September 2017

language of work or name

English

0 references

publication date

1 October 2015

1 reference

Current Pain and Headache Reports

4 September 2017

1 reference

4 September 2017

19

1 reference

4 September 2017

10

1 reference

4 September 2017

50

1 reference

https://scigraph.springernature.com/pub.10.1007/s11916-015-0524-x

4 September 2017

0 references

cites work

Cannabis and the brain

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Cannabidiol--recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

The endocannabinoid system as an emerging target of pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Molecular characterization of a peripheral receptor for cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

21 January 2018

Cannabinoid signalling

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Cannabinoid receptors and their ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Neurotransmission: emerging roles of endocannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Cannabinoids and neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

A comparison of some pharmacological actions of morphine and ?9-tetrahydrocannabinol in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

The enhancement of morphine antinociception in mice by delta9-tetrahydrocannabinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

delta 9-Tetrahydrocannabinol increases proopiomelanocortin gene expression in the arcuate nucleus of the rat hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Delta9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Cannabidiol: an overview of some pharmacological aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

The pharmacologic and clinical effects of medical cannabis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Modelling of the concentration--effect relationship of THC on central nervous system parameters and heart rate -- insight into its mechanisms of action and a tool for clinical research and development of cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Plasma delta-9-tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Biomarkers for the effects of cannabis and THC in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Cannabinoid-hormone interactions in the regulation of motivational processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Medical marijuana and the developing role of the pharmacist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Plasma cannabinoid pharmacokinetics following controlled oral delta9-tetrahydrocannabinol and oromucosal cannabis extract administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Non-acute (residual) neurocognitive effects of cannabis use: a meta-analytic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Persistent cannabis users show neuropsychological decline from childhood to midlife

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Effect of long-term cannabis use on axonal fibre connectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Correlations between cannabis use and IQ change in the Dunedin cohort are consistent with confounding from socioeconomic status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Marijuana and medicine: assessing the science base: a summary of the 1999 Institute of Medicine report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Analgesic Effect of Delta‐9‐Tetrahydrocannabinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

The analgesic properties of delta-9-tetrahydrocannabinol and codeine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Effect of a nitrogen analog of tetrahydrocannabinol on cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Effect of benzopyranoperidine, a Δ-9-THC congener, on pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Smoked cannabis for chronic neuropathic pain: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

A multicenter dose-escalation study of the analgesic and adverse effects of an oral cannabis extract (Cannador) for postoperative pain management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Lack of analgesic efficacy of oral delta-9-tetrahydrocannabinol in postoperative pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Effects of nabilone, a synthetic cannabinoid, on postoperative pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Effects of intravenous tetrahydrocannabinol on experimental and surgical pain. Psychological correlates of the analgesic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Initial experiences with medicinal extracts of cannabis for chronic pain: results from 34 'N of 1' studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

A peripherally restricted cannabinoid receptor agonist produces robust anti-nociceptive effects in rodent models of inflammatory and neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Reply to Rogeberg and Daly: No evidence that socioeconomic status or personality differences confound the association between cannabis use and IQ decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Respiratory and immunologic consequences of marijuana smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Medical consequences of marijuana use: a review of current literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

The adverse health effects of chronic cannabis use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Effects of cannabis on lung function: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

21 January 2018

Cannabis use and cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Epidemiologic review of marijuana use and cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-015-0524-X

Pharmacology and stereoselectivity of structurally novel cannabinoids in mice

21 January 2018

1 reference

12 December 2020

Effects on the immune system.

1 reference

12 December 2020

Effects of cannabinoids on neurotransmission.

1 reference

12 December 2020

Pharmacological actions of cannabinoids.

1 reference

12 December 2020

Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man.

1 reference

12 December 2020

Reply to Moffitt et al.: Causal inference from observational data remains difficult

1 reference

12 December 2020

A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms

1 reference

12 December 2020

Retrograde signalling by endocannabinoids

1 reference

12 December 2020

The role of endogenous opioids in enhancing the antinociception produced by the combination of delta 9-tetrahydrocannabinol and morphine in the spinal cord

1 reference

12 December 2020

Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women

1 reference

12 December 2020

Evaluation of intramuscular levonantradol and placebo in acute postoperative pain

1 reference

12 December 2020

Cannabinoid pharmacology: the first 66 years

1 reference

12 December 2020

Effects of cannabis on pulmonary structure, function and symptoms.

1 reference

12 December 2020

10.1007/S11916-015-0524-X

Identifiers

DOI

1 reference

Dimensions Publication ID

4 September 2017

0 references

1 reference